These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells. Vert A; Castro J; Ribó M; Benito A; Vilanova M Oncotarget; 2016 Apr; 7(14):18309-24. PubMed ID: 26918450 [TBL] [Abstract][Full Text] [Related]
25. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27 Shen X; Xu X; Xie C; Liu H; Yang D; Zhang J; Wu Q; Feng W; Wang L; Du L; Xuan L; Meng C; Zhang H; Wang W; Wang Y; Xie T; Huang Z Cell Prolif; 2020 Feb; 53(2):e12734. PubMed ID: 31863533 [TBL] [Abstract][Full Text] [Related]
26. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway. Li A; Wang J; Wu M; Zhang X; Zhang H Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792 [TBL] [Abstract][Full Text] [Related]
27. Multiple mechanisms for p27(Kip1) translocation and degradation. Susaki E; Nakayama KI Cell Cycle; 2007 Dec; 6(24):3015-20. PubMed ID: 18075313 [TBL] [Abstract][Full Text] [Related]
28. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665 [TBL] [Abstract][Full Text] [Related]
29. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization. Indovina P; Giorgi F; Rizzo V; Khadang B; Schenone S; Di Marzo D; Forte IM; Tomei V; Mattioli E; D'Urso V; Grilli B; Botta M; Giordano A; Pentimalli F Oncogene; 2012 Feb; 31(7):929-38. PubMed ID: 21785466 [TBL] [Abstract][Full Text] [Related]
32. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor. Zeng Y; Hirano K; Hirano M; Nishimura J; Kanaide H Biochem Biophys Res Commun; 2000 Jul; 274(1):37-42. PubMed ID: 10903892 [TBL] [Abstract][Full Text] [Related]
33. [Expression and relationship of p27(kip1) and its related molecules Jab1 and CRM1 during proliferation of lymphoma cells U937]. Wang YC; Zhang DM; Shen AG; Lu JX; Shao XY; He S; Cheng C Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):657-61. PubMed ID: 18246793 [TBL] [Abstract][Full Text] [Related]
35. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro. Jiang D; Wang X; Liu X; Li F Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153 [TBL] [Abstract][Full Text] [Related]
36. miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression. Wang DD; Li J; Sha HH; Chen X; Yang SJ; Shen HY; Zhong SL; Zhao JH; Tang JH Gene; 2016 Sep; 590(1):44-50. PubMed ID: 27282281 [TBL] [Abstract][Full Text] [Related]
37. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301 [TBL] [Abstract][Full Text] [Related]
38. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Fredersdorf S; Burns J; Milne AM; Packham G; Fallis L; Gillett CE; Royds JA; Peston D; Hall PA; Hanby AM; Barnes DM; Shousha S; O'Hare MJ; Lu X Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6380-5. PubMed ID: 9177226 [TBL] [Abstract][Full Text] [Related]
39. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Hung WC; Chang HC; Pan MR; Lee TH; Chuang LY Mol Pharmacol; 2000 Dec; 58(6):1398-403. PubMed ID: 11093779 [TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. Lu Y; Zi X; Pollak M Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]